The market performance of Brainstorm Cell Therapeutics, Inc.’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $3.46 on 03/31/23, while the lowest value for the same duration was $0.13 on 10/31/23.
52-week price history of BCLI Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Brainstorm Cell Therapeutics, Inc.’s current trading price is -89.72% away from its 52-week high, while its distance from the 52-week low is 165.45%. The stock’s price range during this period has spanned from $0.13 to $3.46. In the Healthcare sector, the Brainstorm Cell Therapeutics, Inc.’s shares surpassed a trading volume of approximately 0.66 million for the day, which was noticeably lower compared to the average daily volume of 9.1.32 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly rise of 51.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.42M and boasts a workforce of 43 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2792, with a change in price of +0.2060. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 1,926,327 in trading volume during the last 100 days, posting a change of +133.77%.
BCLI Stock Stochastic Average
Today’s raw stochastic average for Brainstorm Cell Therapeutics, Inc. over the last 50 days is 60.16%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 79.79%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 62.44% and 55.43%, respectively.
BCLI Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 30.29% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -63.11%. Over the past 30 days, the price of BCLI has leaped by -4.82%. And in the last five days, it has surged by 15.45%.
